Cargando…
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
BACKGROUND: Macrophages play a pivotal role in atherosclerotic plaque development. Recent evidence has suggested the glucagon-like peptide-1 receptor (GLP-1R) agonist, liraglutide, can attenuate pro-inflammatory responses in macrophages. We hypothesized that liraglutide could limit atherosclerosis p...
Autores principales: | Bruen, Robyn, Curley, Sean, Kajani, Sarina, Crean, Daniel, O’Reilly, Marcella E., Lucitt, Margaret B., Godson, Catherine G., McGillicuddy, Fiona C., Belton, Orina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674826/ https://www.ncbi.nlm.nih.gov/pubmed/29110715 http://dx.doi.org/10.1186/s12933-017-0626-3 |
Ejemplares similares
-
Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
por: Kajani, Sarina, et al.
Publicado: (2018) -
miR-155 in the Resolution of Atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2019) -
Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages
por: O'Reilly, Marcella E., et al.
Publicado: (2018) -
Sodium salicylate rewires hepatic metabolic pathways in obesity and attenuates IL-1β secretion from adipose tissue: The implications for obesity-impaired reverse cholesterol transport
por: Kajani, Sarina, et al.
Publicado: (2021) -
M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis
por: de Gaetano, Monica, et al.
Publicado: (2016)